Apple has recently unveiled that medical apps available on the App Store in the United States, United Kingdom, and European Economic Area (EEA) will now display new labels. These labels will clearly denote whether an app is classified as a 'regulated medical device.' The classification criteria encompass the following: whether the app functions autonomously or as a component of a medical system for the diagnosis, prevention, monitoring, or treatment of diseases; or whether it is identified as 'often involving medical or therapeutic information' in the App Store's age rating questionnaire.

Developers are obligated to submit regulatory details, such as the EU Single Registration Number (SRN) or the U.S. FDA operator number, through Apple's backend system. Users will then have the ability to view certification data, statements of intended use, and safety notices on the app's detail page. These new regulations take effect immediately for newly listed apps. Existing apps, on the other hand, are required to complete their declarations by early 2027. Apps that fail to meet this deadline will have their privileges for version updates suspended.